Giulia Marvaso, Giulia Corrao, Ilaria Repetti, Chiara Lorubbio, Federica Bellerba, Mattia Zaffaroni, Maria Giulia Vincini, Dario Zerini, Sarah Alessi, Stefano Luzzago, Francesco Alessandro Mistretta, Cristiana Fodor, Raffaella Cambria, Federica Cattani, Francesco Ceci, Gennaro Musi, Ottavio De Cobelli, Thomas Zilli, Sara Gandini, Roberto Orecchia, Giuseppe Petralia, Barbara Alicja Jereczek-Fossa
AIM: The present work reports updated oncological results and patients-reported outcomes at 5 years of phase II trial "Short-term high precision RT for early prostate cancer with SIB to the dominant intraprostatic lesion (DIL) for patients with early-stage PCa". METHODS: Data from patients enrolled within AIRC IG-13218 (NCT01913717) trial were analyzed. Clinical and GU/GI toxicity assessment and PSA measurements were performed every 3 months for at least 2 years after RT end...
March 16, 2024: World Journal of Urology